| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,731 |
29,181 |
$1.26M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,737 |
14,328 |
$651K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
16,113 |
15,689 |
$581K |
| 80053 |
Comprehensive metabolic panel |
37,278 |
35,861 |
$342K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,750 |
9,301 |
$175K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
39,273 |
37,413 |
$156K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,742 |
4,658 |
$146K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,492 |
817 |
$124K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,151 |
7,456 |
$83K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,867 |
2,635 |
$83K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,475 |
2,443 |
$82K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
152 |
149 |
$66K |
| 81001 |
|
17,963 |
17,482 |
$64K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
825 |
485 |
$56K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,030 |
1,875 |
$46K |
| 93325 |
|
753 |
742 |
$44K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
404 |
399 |
$42K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
307 |
305 |
$35K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
537 |
521 |
$30K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,338 |
657 |
$26K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
74 |
72 |
$26K |
| 70450 |
Computed tomography, head or brain; without contrast material |
343 |
329 |
$23K |
| G0378 |
Hospital observation service, per hour |
720 |
501 |
$22K |
| 84484 |
|
2,488 |
2,270 |
$22K |
| 84703 |
|
2,409 |
2,348 |
$22K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
204 |
199 |
$20K |
| 0240U |
|
177 |
177 |
$17K |
| 83690 |
|
2,651 |
2,571 |
$17K |
| 86140 |
|
2,864 |
2,791 |
$14K |
| 93304 |
|
201 |
199 |
$14K |
| 71046 |
Radiologic examination, chest; 2 views |
1,290 |
1,264 |
$14K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
34 |
34 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
340 |
228 |
$12K |
| 83735 |
|
2,209 |
2,125 |
$12K |
| 93320 |
|
307 |
305 |
$12K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
158 |
126 |
$12K |
| 93321 |
|
285 |
279 |
$12K |
| 59025 |
Fetal non-stress test |
355 |
287 |
$12K |
| 87081 |
|
1,383 |
1,377 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
617 |
536 |
$11K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
70 |
70 |
$9K |
| 87507 |
|
14 |
12 |
$9K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
61 |
60 |
$9K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
67 |
66 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
442 |
432 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,216 |
1,180 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
185 |
183 |
$7K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
40 |
40 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
118 |
116 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
118 |
116 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
481 |
467 |
$5K |
| 80061 |
Lipid panel |
813 |
800 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
60 |
60 |
$5K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
13 |
$4K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
25 |
25 |
$4K |
| 83605 |
|
550 |
508 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
94 |
92 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
71 |
70 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
445 |
435 |
$4K |
| 64483 |
|
55 |
53 |
$4K |
| 85610 |
|
1,431 |
1,132 |
$4K |
| 87807 |
|
189 |
184 |
$3K |
| 80164 |
|
613 |
582 |
$3K |
| 85730 |
|
792 |
765 |
$3K |
| 84145 |
|
162 |
157 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
323 |
321 |
$3K |
| 83880 |
|
193 |
184 |
$2K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
29 |
28 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
986 |
535 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
46 |
46 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
224 |
157 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
733 |
552 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
441 |
437 |
$2K |
| 87040 |
|
153 |
123 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,012 |
1,484 |
$2K |
| 96376 |
|
87 |
77 |
$2K |
| 62369 |
|
25 |
24 |
$1K |
| 87077 |
|
160 |
146 |
$1K |
| 84439 |
|
127 |
122 |
$1K |
| 87186 |
|
123 |
119 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
37,745 |
33,656 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,571 |
1,217 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
796 |
761 |
$1K |
| 87808 |
|
88 |
86 |
$1K |
| 82247 |
|
145 |
108 |
$977.19 |
| 73502 |
|
28 |
27 |
$926.07 |
| 77336 |
|
20 |
12 |
$860.79 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
21 |
21 |
$857.81 |
| 82803 |
|
83 |
77 |
$830.75 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$762.21 |
| 81025 |
|
94 |
92 |
$755.21 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
263 |
256 |
$748.87 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,650 |
1,318 |
$740.28 |
| 87205 |
|
141 |
137 |
$736.83 |
| 85379 |
|
85 |
84 |
$728.44 |
| 93017 |
|
42 |
37 |
$708.75 |
| 74018 |
|
52 |
49 |
$674.43 |
| 88304 |
|
58 |
58 |
$670.72 |
| 84702 |
|
61 |
54 |
$648.45 |
| 73562 |
|
46 |
41 |
$612.79 |
| 72100 |
|
29 |
29 |
$608.96 |
| 71045 |
Radiologic examination, chest; single view |
131 |
126 |
$606.07 |
| 64484 |
|
13 |
13 |
$539.02 |
| J1815 |
Injection, insulin, per 5 units |
58 |
30 |
$482.42 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
903 |
773 |
$476.41 |
| 73630 |
|
36 |
32 |
$438.13 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
19 |
14 |
$437.34 |
| 73030 |
|
29 |
29 |
$430.40 |
| 73610 |
|
34 |
32 |
$417.00 |
| 87070 |
|
61 |
57 |
$409.41 |
| 86850 |
|
60 |
58 |
$395.15 |
| 83525 |
|
26 |
25 |
$379.20 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
512 |
511 |
$375.10 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
28 |
28 |
$356.57 |
| 82550 |
|
42 |
36 |
$322.12 |
| 86308 |
|
37 |
37 |
$303.15 |
| 87147 |
|
33 |
33 |
$293.71 |
| 86901 |
|
59 |
57 |
$283.41 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
144 |
127 |
$279.88 |
| 81003 |
|
379 |
328 |
$277.25 |
| 82248 |
|
77 |
60 |
$276.14 |
| 73130 |
|
17 |
16 |
$274.78 |
| 85651 |
|
48 |
48 |
$265.16 |
| 86592 |
|
41 |
41 |
$258.24 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
129 |
88 |
$251.11 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
30 |
28 |
$222.64 |
| 86900 |
|
59 |
57 |
$222.44 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
47 |
37 |
$216.64 |
| 85027 |
|
39 |
35 |
$197.09 |
| 83655 |
|
12 |
12 |
$188.64 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
130 |
107 |
$148.54 |
| 73590 |
|
14 |
13 |
$147.79 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
71 |
54 |
$147.05 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
617 |
601 |
$145.45 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
677 |
628 |
$126.58 |
| 99152 |
|
34 |
32 |
$108.83 |
| 82607 |
|
14 |
13 |
$107.43 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
16 |
12 |
$98.26 |
| 82272 |
|
31 |
30 |
$89.54 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
643 |
592 |
$76.62 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
88 |
83 |
$72.59 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
137 |
106 |
$67.46 |
| J2704 |
Injection, propofol, 10 mg |
133 |
130 |
$65.35 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
28 |
25 |
$54.22 |
| 99153 |
Mod sedat endo service >5yrs |
13 |
12 |
$54.12 |
| J2060 |
Injection, lorazepam, 2 mg |
51 |
45 |
$44.13 |
| 87340 |
|
18 |
18 |
$31.76 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
13 |
13 |
$22.84 |
| J1644 |
Injection, heparin sodium, per 1000 units |
43 |
26 |
$17.73 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
15 |
15 |
$12.09 |
| J1630 |
Injection, haloperidol, up to 5 mg |
65 |
60 |
$10.12 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
14 |
12 |
$9.93 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
14 |
12 |
$9.01 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
29 |
26 |
$7.82 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
25 |
25 |
$7.50 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
335 |
319 |
$6.07 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
5,893 |
4,630 |
$0.02 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
63 |
58 |
$0.00 |
| C1780 |
Lens, intraocular (new technology) |
14 |
12 |
$0.00 |
| 36600 |
|
50 |
47 |
$0.00 |
| 36416 |
|
62 |
45 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
62 |
61 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
29 |
28 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
15 |
15 |
$0.00 |